CVR number 13918600
Industry 46.9000 Non-specialised wholesale trade

VITROLINE ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  2.1% 2.1% 2.1% 2.1% 2.1%  
Bankruptcy risk  22.6% 16.2% 8.8% 15.5% 20.4%  
Credit score (0-100)  5 11 27 12 4  
Credit rating  B BB BB BB B  
Credit limit (kDKK)  -0.0 -0.0 0.0 0.0 -0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  1,499 2,709 3,124 2,292 1,793  
EBITDA  -240 775 823 371 -4.8  
EBIT  -322 693 789 339 -4.8  
Pre-tax profit (PTP)  -388.6 351.3 1,041.1 -14.5 -1,114.9  
Net earnings  -383.8 282.6 868.9 -120.8 -1,130.2  
Pre-tax profit without non-rec. items  -389 351 1,041 -14.5 -1,115  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  150 68.4 34.2 0.0 0.0  
Shareholders equity total  -1,406 -1,124 -255 -375 -1,506  
Interest-bearing liabilities  786 96.0 297 701 1,295  
Balance sheet total (assets)  3,432 4,001 4,641 3,995 3,502  
Net Debt  763 14.1 235 649 1,239  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,499 2,709 3,124 2,292 1,793  
Gross profit growth  -55.5% 80.8% 15.3% -26.6% -21.8%  
Employees  4 4 3 3 3  
Employee growth %  0.0% 0.0% -25.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,432 4,001 4,641 3,995 3,502  
Balance sheet change%  -22.6% 16.6% 16.0% -13.9% -12.3%  
Added value  -240.0 775.1 823.1 373.2 -4.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -164 -164 -68 -66 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 2.0 3.0 -1.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -21.5% 25.6% 25.3% 14.8% -0.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -6.2% 11.5% 21.5% 6.6% 2.7%  
ROI %  -28.1% 92.4% 128.4% 26.9% 12.5%  
ROE %  -9.8% 7.6% 20.1% -2.8% -30.2%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  -29.1% -21.9% -5.2% -8.6% -30.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -318.0% 1.8% 28.6% 174.8% -25,548.5%  
Gearing %  -55.9% -8.5% -116.8% -186.8% -86.0%  
Net interest  0 0 0 0 0  
Financing costs %  6.0% 12.7% 18.1% 64.3% 124.2%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.3 0.4 0.3 0.3 0.7  
Current Ratio  0.6 0.7 0.6 0.7 1.1  
Cash and cash equivalent  22.7 81.9 62.2 52.3 55.8  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -2,002.0 -1,566.6 -1,373.6 -862.4 276.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  -60 194 274 124 -2  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -60 194 274 124 -2  
EBIT / employee  -80 173 263 113 -2  
Net earnings / employee  -96 71 290 -40 -377